E. Benjamin, Heart Disease and Stroke Statistics-2017 Update: A Report From the, American Heart Association. Circulation, vol.135, pp.146-603, 2017.

P. De-groote, B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure, J Am Coll Cardiol, vol.43, pp.1584-1589, 2004.

M. Fertin, Usefulness of circulating biomarkers for the prediction of left ventricular remodeling after myocardial infarction, Am. J. Cardiol, p.110, 2012.

W. Ouwerkerk, A. Voors, and A. Zwinderman, Factors Influencing the Predictive Power of Models for Predicting Mortality and/or Heart Failure Hospitalization in Patients With Heart Failure, JAAC Hear. Fail, vol.2, pp.429-436, 2014.

G. Lemesle, Multimarker proteomic profiling for the prediction of cardiovascular mortality in patients with chronic heart failure, PLoS One, vol.10, pp.1-12, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02267435

T. Cao, Using matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) profiling in order to predict clinical outcomes of patients with heart failure, Clin. Proteomics, vol.15, p.35, 2018.

F. J. Azuaje, Systems-based approaches to cardiovascular biomarker discovery, Circ. Cardiovasc. Genet, vol.5, pp.360-367, 2012.

H. Gaggin, Systematic Evaluation of Endothelin 1 Measurement Relative to Traditional and Modern Biomarkers for Clinical Assessment and Prognosis in Patients With Chronic Systolic Heart Failure: Serial Measurement and Multimarker Testing, Am J Clin Pathol, vol.147, pp.461-472, 2017.

N. E. Ibrahim and J. L. Januzzi, Established and Emerging Roles of Biomarkers in Heart Failure, Circ Res, vol.123, pp.614-629, 2018.

L. Gold, Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery, PLoS One, vol.5, p.15004, 2010.

C. H. Kim, Stability and reproducibility of proteomic profiles measured with an aptamer-based platform, Sci. Rep, vol.8, p.8382, 2018.

J. Candia, Assessment of Variability in the SOMAscan Assay. Sci. Rep, vol.7, p.14248, 2017.

R. M. Ostroff, Unlocking biomarker discovery: Large scale application of aptamer proteomic technology for early detection of lung cancer, PLoS One, vol.5, pp.1-10, 2010.

M. Sattlecker, Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology, vol.10, pp.724-734, 2014.

D. Ngo, Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular Disease, Circulation, vol.134, pp.270-285, 2016.

P. Ganz, Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients With Stable Coronary Heart Disease, JAMA, vol.315, p.2532, 2016.

T. Tanaka, Plasma proteomic signature of age in healthy humans, Aging Cell, vol.17, pp.1-13, 2018.

J. Mcmurray, Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure, N. Engl. J. Med, vol.371, pp.993-1004, 2014.

H. Sun and Y. Wang, Interferon regulatory factors in heart: stress response beyond inflammation, Hypertension, vol.63, pp.663-664, 2014.

S. Y. Lim, Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapytreated melanoma patients, Biomark. Res, vol.5, p.32, 2017.

M. Kurdi, C. Zgheib, and G. Booz, Recent Developments on the Crosstalk Between STAT3 and Inflammation in Heart Function and Disease, Front Immunol, vol.9, p.3029, 2018.

N. Gerits, The transcriptional regulation and cell-specific expression of the mapk-activated protein kinase MK5, Cell. Mol. Biol. Lett, vol.14, pp.548-574, 2009.

P. Sahadevan and B. G. Allen, MK5: A novel regulator of cardiac fibroblast function?, IUBMB Life, vol.69, pp.785-794, 2017.

H. Chen, Cathepsin S-mediated fibroblast trans-differentiation contributes to left ventricular remodelling after myocardial infarction, Cardiovasc Res, vol.100, pp.84-94, 2013.

A. Frey, Complement C3c as a biomarker in heart failure, Mediators Inflamm, p.2013, 2013.

T. Gombos, Complement anaphylatoxin C3a as a novel independent prognostic marker in heart failure, Clin. Res. Cardiol, vol.101, pp.607-615, 2012.

N. Silva, E. Patrício, P. Bettencourt, and J. Guimarães, Evaluation of Innate Immunity Biomarkers on Admission and at Discharge From an Acute Heart Failure Episode, J Clin Lab Anal, vol.30, pp.1183-1190, 2016.

A. H. Nakajima and K. Koizumi, Family with sequence similarity 107: A family of stress responsive small proteins with diverse functions in cancer and the nervous system (Review), Biomed. Reports, vol.2, pp.321-325, 2014.

X. Li, Z. Liu, Z. Cheng, and X. Cheng, Cysteinyl Cathepsins: Multifunctional Enzymes in Cardiovascular Disease, Chonnam Med. J, vol.48, p.77, 2012.

E. Jobs, Association Between Serum Cathepsin S. JAMA, vol.306, pp.1113-11121, 2011.

S. Liu, Soluble Glycoprotein 130 and Heat Shock Protein 27 as Novel Candidate Biomarkers of Chronic Heart Failure with Preserved Ejection Fraction, Hear. Lung Circ, vol.25, pp.1000-1006, 2016.

J. Wuopio, Cathepsin B and S as markers for cardiovascular risk and all-cause mortality in patients with stable coronary heart disease during 10 years: a CLARICOR trial sub-study, Atherosclerosis, vol.278, pp.97-102, 2018.

F. Spinale, Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function, Physiol. Rev, vol.87, pp.1285-1342, 2007.

K. Y. Deleon-pennell, C. A. Meschiari, M. Jung, and M. L. Lindsey, In Prog Mol Biol Transl Sci, vol.147, pp.75-100, 2017.

T. Morishita, Association between matrix metalloproteinase-9 and worsening heart failure events in patients with chronic heart failure, ESC Hear. Fail, vol.4, pp.321-330, 2017.

A. Timotin, Differential protein profiling as a potential multi-marker approach for obese patients with heart failure: A retrospective study, Sci. Rep, vol.8, p.7894, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01890002

R. Rana, Noncanonical Matrix Metalloprotease 1-Protease-Activated Receptor 1 Signaling Drives Progression of Atherosclerosis, Arterioscler. Thromb. Vasc. Biol, vol.38, pp.1368-1380, 2018.

B. López, Myocardial Collagen Cross-Linking Is Associated With Heart Failure Hospitalization in Patients With Hypertensive Heart Failure, J Am Coll Cardiol, vol.67, pp.251-260, 2016.

S. Ravassa, Phenotyping of myocardial fibrosis in hypertensive patients with heart failure. Influence on clinical outcome, J. Hypertens, vol.35, pp.853-861, 2017.

H. Williams, J. Johnson, C. Jackson, S. White, and S. George, MMP-7 mediates cleavage of N-cadherin and promotes smooth muscle cell apoptosis, Cardiovasc. Res, vol.87, pp.137-146, 2010.

M. R. Zile, Plasma Biomarkers That Reflect Determinants of Matrix Composition Identify the Presence of Left Ventricular Hypertrophy and Diastolic Heart Failure, Circ. Heart. Fail, vol.4, pp.246-256, 2011.

B. B. Sun, Genomic atlas of the human plasma proteome, Nature, vol.558, pp.73-79, 2018.

S. Kiddle, Plasma protein biomarkers of Alzheimer's disease endophenotypes in asymptomatic older twins: early cognitive decline and regional brain volumes, Transl Psychiatry, vol.5, p.584, 2015.

Y. Benjamini and Y. Hochberg, Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple. Testing, J. R. Stat. Soc. Ser. B, vol.57, pp.289-300, 1995.

P. Shannon, Cytoscape: a software environment for integrated models of biomolecular interaction networks, Genome Res, vol.13, pp.2498-2504, 2003.

M. Rosvall and C. Bergstrom, Maps of random walks on complex networks reveal community structure, Proc Natl Acad Sci, vol.105, pp.1118-1141, 2008.

G. Csardi and T. Nepusz, The igraph software package for complex network research, Inter J. Complex Syst, vol.1695, 2006.

A. E. Hoerl and R. W. Kennard, Ridge Regression: Biased Estimation for Nonorthogonal Problems, Technometrics, vol.12, pp.55-67, 1970.

R. Tibshirani, Regression Shrinkage and Selection via the Lasso, J. R. Stat. Soc. Ser. B, vol.58, pp.267-288, 1996.

H. Zou, The Adaptive Lasso and Its Oracle Properties, J. Am. Stat. Assoc, vol.101, pp.1418-1429, 2006.

J. Friedman, T. Hastie, and R. Tibshirani, Regularization Paths for Generalized Linear Models via Coordinate Descent, J. Stat. Softw, vol.33, pp.1-20, 2010.